LCH-I: A randomized trial of etoposide vs. vinblastine in disseminated langerhans cell histiocytosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LCH-I: A randomized trial of etoposide vs. vinblastine in disseminated langerhans cell histiocytosis

Published:1994 Issue:2 Volume:23 Page:107-110
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Ladisch Stephan,Gadner Helmut,Arico Maurizio,Broadbent Valerie,Grois Nicole,Jacobson Ake,Komp Diane,Nicholson H. Stacy

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology, and Child Health

Reference29 articles.

1. Use of VP-16–213 in the treatment of familial erythrophagocytic lymphohistiocytosis

2. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16–213

3. Etoposide (VP16) in the treatment of multisystem langerhans cell histiocytosis (histiocytosis X)

4. Etoposide in recurrent childhood Langerhans' cell histiocytosis: An Italian cooperative study

5. Malignant histiocytosis. Response to VP-16-213 and cytosine arabinoside

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Helmut Gadner: A Charismatic Leader, Visionary, and Pioneer in Pediatric Oncology;Cureus;2024-09-04

2. Early response to chemotherapy in children with Langerhans cell histiocytosis predicts long-term disease-free survival;Indian Journal of Cancer;2023-01

3. Langerhans Cell Histiocytosis: A Population-based Study of Anatomical Distribution and Treatment Patterns;Journal of Bone Oncology;2022-10

4. Langerhans cell histiocytosis of single‐system multifocal bone, including the mandible, in a 22‐month‐old child: A case report;Oral Science International;2022-06-05

5. Incidence, Clinical Features, and Outcomes of Langerhans Cell Histiocytosis in the United States;Journal of Pediatric Hematology/Oncology;2022-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3